VERV

Verve Therapeutics

Delisted

VERV was delisted on the 24th of July, 2025.

69 hedge funds and large institutions have $2.25B invested in Verve Therapeutics in 2021 Q2 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$661M
2 +$232M
3 +$208M
4
CC
Casdin Capital
New York
+$183M
5
RG
Redmile Group
California
+$117M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
51
$767K
52
$603K
53
$572K
54
$476K
55
$428K
56
$411K
57
$375K
58
$361K
59
$343K
60
$322K
61
$301K
62
$149K
63
$96K
64
$92K
65
$22K
66
$21K
67
$18K
68
$6K
69
$3.92K